Logo

Biogen Idec Licenses InforSense Workflow Software

Jun 14, 2005

NEW YORK, June 14 (GenomeWeb News) - InforSense has licensed its workflow software to biotechnology company Biogen Idec, the London-based informatics company said today.

 

Biogen will use both InforSense KDE, the company's workflow software, and InforSense's TextSense text-mining technology to build decision-support software applications.

 

The companies did not disclose the terms of the agreement.

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.